5-ethyl-4-fluoro-1H-pyrazole-3-carboxamide;2-[2-(trifluoromethyl)-4-pyridinyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine
C19H20F4N6O — CID 177050471
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-ethyl-4-fluoro-1H-pyrazole-3-carboxamide;2-[2-(trifluoromethyl)-4-pyridinyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine
5-ethyl-4-fluoro-1H-pyrazole-3-carboxamide;2-[2-(trifluoromethyl)-4-pyridinyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine (PubChem CID 177050471) has the molecular formula C19H20F4N6O and a molecular weight of 424.40 g/mol. Its IUPAC name is 5-ethyl-4-fluoro-1H-pyrazole-3-carboxamide;2-[2-(trifluoromethyl)-4-pyridinyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine.
Molecular Properties
| Compound Name | 5-ethyl-4-fluoro-1H-pyrazole-3-carboxamide;2-[2-(trifluoromethyl)-4-pyridinyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine |
|---|---|
| PubChem CID | 177050471 |
| Molecular Formula | C19H20F4N6O |
| Molecular Weight | 424.40 g/mol |
| Exact Mass | 424.16 |
| IUPAC Name | 5-ethyl-4-fluoro-1H-pyrazole-3-carboxamide;2-[2-(trifluoromethyl)-4-pyridinyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine |
| SMILES | CCc1[nH]nc(C(N)=O)c1F.FC(F)(F)c1cc(-c2cc3n(n2)CCCC3)ccn1 |
| InChI | InChI=1S/C13H12F3N3.C6H8FN3O/c14-13(15,16)12-7-9(4-5-17-12)11-8-10-3-1-2-6-19(10)18-11;1-2-3-4(7)5(6(8)11)10-9-3/h4-5,7-8H,1-3,6H2;2H2,1H3,(H2,8,11)(H,9,10) |
| InChIKey | YLJCFRUEOPXYKC-UHFFFAOYSA-N |
| XLogP | 3.51 |
| TPSA | 102.48 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 424.40 |
| LogP ≤ 5 | 3.51 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177050471 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.